Melanoma Stage I
Oncology·MeSH: Melanoma
7 drugs in development·4 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| Lenvatinib | KYNTRA BIO INC. (KYNB) |
Phase 2(5)
Phase 2/Phase 3(1)
| Drug | Company |
|---|---|
| BNT111 | BioNTech SE (BNTX) |
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma Stage I?
BioSniper tracks 7 drugs in development for Melanoma Stage I across 4 companies.
How many clinical trials target Melanoma Stage I?
There are 1 clinical trial targeting Melanoma Stage I tracked by BioSniper.
Deep-dive into Melanoma Stage I
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis